scPharmaceuticals Inc. (NASDAQ:SCPH announced the pricing of an underwritten public offering of 5,780,347 shares of its common stock at a public offering price of $8.65 per share, before deducting underwriting discounts and commissions and other offering expenses, for gross proceeds of approximately $50.0 million. All shares of common stock to be sold in the offering are being offered by scPharmaceuticals. The Company has also granted the underwriters a 30-day option to purchase from the Company up to an additional 867,052 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on May 26, 2020, subject to customary closing conditions.
Jefferies and SVB Leerink are acting as joint book-running managers for the offering. BMO Capital Markets is acting as a bookrunner for the offering. H.C. Wainwright & Co. is acting as lead manager for the offering.